Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Inhalation Anesthesia Market Size, Share & Trends Analysis & Forecast (2018-2025) - ResearchAndMarkets.com

Research and Markets
Posted on: 08 Nov 18

The "Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Desflurane, Isoflurane), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global inhalation anesthesia market size is expected to reach USD 1.4 billion by 2025, exhibiting 3.5% CAGR during the forecast period.

Increase in number of surgical interventions requiring anesthesia, rising in awareness about delirium, and predictable nature of these drugs are some of the factors expected to drive the market over the forecast period.

These drugs are metabolized through lungs; thus, they have very low chances of interacting with other medicines. Hence, these drugs are the preferred choice for patients who are critically injured and require a shorter duration of anesthesia.

Inhalation anesthesia has an advantage over other intravenous agents and is considered safer by surgeons. Rising adoption of these drugs in major markets such as U.S., Europe, and Japan is expected to drive revenue growth between 2018 and 2025.

The global inhalation anesthesia market, by product, was dominated by sevoflurane with a revenue share of 70% in 2017. Higher preference for sevoflurane over other agents due to comparatively lower delirium, lower resistance, and cost effectiveness owing to shorter induction and wake up time as compared to intravenous drugs are some of the factors contributing to a larger revenue share.

Market Dynamics

Drivers
  • Higher Patient Outcome as Compared to Intravenous Anesthesia
  • Increasing Need to Reduce Hospital Care Cost
  • Rising Number of Surgical Procedures
Restraint
  • Increasing Concern About Greenhouse Gas Emissions

Key Topics Covered

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope

Chapter 4 Inhalation Anesthesia Market: Product Estimates & Trend Analysis

Chapter 5 Inhalation Anesthesia Market: Application Estimates & Trend Analysis

Chapter 6 Inhalation Anesthesia Market: Regional Estimates & Trend Analysis

Chapter 7 Competitive Landscape

  • Halocarbon Products Corporation
  • Baxter
  • Hikma Pharmaceuticals PLC
  • Lunan Pharmaceutical Group Co. Ltd.
  • Piramal Enterprises Limited
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Fresenius Kabi AG
  • AbbVie Inc.

For more information about this report visit https://www.researchandmarkets.com/research/zkf35f/global_inhalation?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181108005403/en/

Business Wire
www.businesswire.com

Last updated on: 08/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.